dr. Z.H. (Saskia) Rittersma

A computerised decision support system for cardiovascular risk management 'live' in the electronic health record environment:development, validation and implementation-the Utrecht Cardiovascular Cohort Initiative

Groenhof T K J, Rittersma Z H, Bots M L, Brandjes M, Jacobs J J L, Grobbee D E, van Solinge W W, Visseren F L J, Haitjema S, Asselbergs F W, 1 aug 2019, In: Netherlands Heart Journal. 27 , p. 435-442 8 p.

Incidence, angiographic and clinical predictors, and impact of stent thrombosis:a 6-year survey of 6,545 consecutive patients

Rozemeijer R., Wong C. Wing, Leenders G., Timmers L., Koudstaal S., Rittersma S. Z., Kraaijeveld A., Bots M., Doevendans P., Stella P., Voskuil M. 20 mrt 2019, In: Netherlands Heart Journal. 27 , p. 321-329

Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent

Rozemeijer Rik, Stein Mera, Voskuil Michiel, van den Bor Rutger, Frambach Peter, Pereira Bruno, Koudstaal Stefan, Leenders Geert E, Timmers Leo, Rittersma Saskia Z, Kraaijeveld Adriaan O, Agostoni Pierfrancesco, Roes Kit C, Doevendans Pieter A, Stella Pieter R, 2 jan 2019, In: Circulation. 139 , p. 67-77 11 p.

One-year clinical outcomes of patients treated with polymer-free amphilimus-eluting stents or zotarolimus-eluting stents:A propensity-score adjusted analysis

Rozemeijer Rik, van Muiden Ivar G, Koudstaal Stefan, Leenders Geert E, Timmers Leo, Rittersma Saskia Z, Kraaijeveld Adriaan O, Doevendans Pieter A, Voskuil Michiel, Stella Pieter R 2 jan 2019, In: Catheterization and Cardiovascular Interventions. 94 , p. 61-69 9 p.

Clinical outcomes of complex real-world diabetic patients treated with amphilimus sirolimus-eluting stents or zotarolimus-eluting stents:A single-center registry

Rozemeijer Rik, Benedetto Daniela, Kraaijeveld Adriaan O., Voskuil Michiel, Stein Mèra, Timmers Leo, Rittersma Saskia Z., Agostoni Pierfrancesco, Doevendans Pieter A., Stella Pieter R. jul 2018, In: Cardiovascular revascularization medicine : including molecular interventions. 19 , p. 521-525

Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial:A multicenter randomized clinical trial

Rozemeijer Rik, Stein Mèra, Frambach Peter, Voskuil Michiel, Kraaijeveld Adriaan O, Rodríguez-Olivares Ramón, Timmers Leo, Pereira Bruno, Rittersma Saskia, Agostoni Pierfrancesco, Doevendans Pieter A, Stella Pieter R 15 feb 2018, In: Catheterization and Cardiovascular Interventions. 91 , p. 410-416

Clinical outcomes of diabetic patients treated with an amphilimus-eluting stent and a short duration of dual antiplatelet therapy in routine clinical practice:first results of the Utrecht Cre8 (U-Cre8) Registry

Rozemeijer Rik, Stein Mera, Voskuil Michiel, Kraaijeveld Adriaan, Timmers Leo, Rodríguez-Olivares Ramon, Rittersma Saskia, Stella Pieter 1 nov 2016, In: Journal of the American College of Cardiology. 68 , p. B109

Severity of stable coronary artery disease and its biomarkers differ between men and women undergoing angiography

Gijsberts Crystel M. , Gohar Aisha , Ellenbroek Guilielmus H.J.M. , Hoefer Imo E., de Kleijn Dominique P. V. , Asselbergs Folkert W., Nathoe Hendrik M., Agostoni Pierfrancesco, Rittersma Saskia Z. H. , Pasterkamp Gerard, Appelman Yolande, den Ruijter Hester M. jul 2015, In: Atherosclerosis. 241 , p. 234-240 7 p.

Inter-Ethnic Differences in Quantified Coronary Artery Disease Severity and All-Cause Mortality among Dutch and Singaporean Percutaneous Coronary Intervention Patients

Gijsberts Crystel M, Seneviratna Aruni, Höfer IE, Agostoni Pierfrancesco, Rittersma Saskia Z. H. , Pasterkamp Gerard, Hartman Mikael, Pinto de Carvalho Leonardo, Richards A Mark, Asselbergs Folkert W, de Kleijn Dominique P V, Chan Mark Y 2015, In: PLoS ONE [E]. 10 14 p.

Deze website maakt gebruik van cookies

dr. Z.H. (Saskia) Rittersma Assistant Professor - medical

Contact

Research Output (9)